Umoja Biopharma
Highly Engaged Employees
Blood & Organ Banks · Washington, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1150 Eastlake Ave E Ste 400, Seattle, Wa...Website
www.umoja-biopharma.comRevenue
$40.2 MillionIndustry
About Umoja Biopharma
Umoja Biopharma is pioneering immunotherapy by developing in vivo CAR T cell therapies aimed at improving cancer treatment accessibility. Their flagship VivoVec platform generates CAR T cells directly within a patient's body, eliminating the lengthy manufacturing process associated with traditional therapies. The company employs a fully in-house lentiviral manufacturing model to ensure reliable supply and quality control. Their pipeline focuses on cancer treatments, with potential applications in other medical conditions.Explore more
SIC Code 28,283NAICS Code 32,325Show moreUmoja Biopharma Org Chart
Show More
Compare Similar Companies to Umoja Biopharma
Compare insights from companies similar to Umoja Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Umoja Biopharma Tech Stack
A closer look at the technologies used by Umoja Biopharma
See more technologies
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Umoja Biopharma
Sign Up For FreeTo access detailed company insights
Umoja Biopharma is pioneering immunotherapy by developing in vivo CAR T cell therapies aimed at improving cancer treatment accessibility. Their flagship VivoVec platform generates CAR T cells directly within a patient's body, eliminating the lengthy manufacturing process associated with traditional therapies. The company employs a fully in-house le... Read More
